DRUGS DEVELOPED AT «ARC BASS» WITH M.D. MASHKOVSKII LEAD (REVIEW)-Reference-Cited by-同舟云学术

DRUGS DEVELOPED AT «ARC BASS» WITH M.D. MASHKOVSKII LEAD (REVIEW)

Published:2019-02-14 Issue:1 Volume:8 Page:7-13
ISSN:2305-2066
Container-title:Drug development & registration
language:
Short-container-title:Razrabotka i registraciâ lekarstvennyh sredstv

Author:

Skachilova S. Ya.¹,Ermakova G. A.¹,Zheltukhin N. K.¹,Zueva E. F.¹,Davydova N. K.²

Affiliation:

1. All-Union Research Center for Biological Active Substances Safety «ARC BASS»

2. A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences (INEOS RAS)

Abstract

Introduction. There are presented data on drugs development with M.D. Mashkovskii lead. There are given materials on drugs belonging to important pharmacotherapeutic groups of drugs such as generic and original drugs. Original syntheses of famous generic drugs and improved industrial technologies have been developed. The attention is paid to high quality of produced drugs. More than 200 new molecules were synthesized while developing original structures of nitrobenzamide derivatives. The studies of pharmacological and toxicological characteristics have helped to choose and create original antiarrhythmic nibentan and niferidyl. The drugs are registered in the Ministry of Healthcare of the Russian Federation and included in essential drugs list. Text. VNIKHFI branch called today VNC BAV founded in 1966. M.D. Mashkovskii offered that creation to expand scientific and experimental base of drugs development. It continues to research and develop new drugs including syntheses of original molecules, developing of industrial technology, and preclinical research of pharmacological activities, drug safety, and toxicology. Original synthesis schemes are described shortly in the article. Industrial technologies of pharmacopoeial substance synthesis are developed out of these schemes such as γ-butyric acid, dopamine, analgin for injection, and original drugs nibentan – ((RS) N-[5-(diethylamino)-1-phenylpentyl]-4-nitrobenzamide hydrochloride), niferidyl – N-1-[(4-fluorophenyl)- 2-(1-ethyl-4-piperidyl)ethyl]-4-nitrobenzamide hydrochloride. The release of developed drugs to the national industrial production is specially noted. Conclusion. M.D. Mashkovskii always supported national drugs development by submitting valuable offers, paying constant attention to scientific research, quality of drugs, and drugs production in industrial quantities for securing national healthcare with national drugs.

Publisher

Center of Pharmaceutical Analytics Ltd

Subject

Drug Discovery,Pharmaceutical Science

Reference30 articles.

1. Copyright certificate SU 452196. The method of obtaining gammaaminobutyric acid / Skachilova S. Ya., Pleshakov M. G., Krivashov A. V., Kornilov A. A. – Appl. 12.02.1973, publ. 12.05.1976. (In Russ.).

2. Mashkovskii M. D., Pleshakov M. G., Altshuler R. A., Skachilova S. Ya. New Neurotropic Preparation Aminalon // Chemical Pharmaceutical Journal. 1975; 9: 60–62. (In Russ.).

3. Copyright certificate SU 1094263. Method for producing dopamine / Glushkov R. G., Skachilova S. Ya., Zueva E. F., Sajapina F. A. – Declared. 15.12.1982, registered in the State Register on 22.01.1984 (In Russ.).

4. Copyright certificate SU 1098217. The method of purification of 2-(3,4-hydroxyphenyl)-ethylamine hydrochloride / Skachilova S. Ya., Zueva E. F., Felicyna M. I. – Declared. 15. 06.1982, registered in the State Register on 15. 02.1984 (In Russ.).

5. Copyright certificate SU 1282705. Method for the quantitative determination of 2-(3-methoxy-4-hydroxyphenyl)-ethylamine in dopamine / Skachilova S. Ya., Dozorova I. I., Kolchanova L. A., Zueva E. F. – Appl. 23.03.1985, registered in the State Register 09.08.1986 (In Russ.).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiarrhythmic Activity of Amino Acids Containing Nibentan Derivatives in Case of Symptoms of Occlusive and Reperfusion Arrhythmias;Drug development & registration;2023-09-01

2. Design, Synthesis of Novel N-Substituted 6α-Piperazinomethyl-Δ4-3,17-diketosteroids and their Antimicrobial Activity Evaluation;Current Organic Chemistry;2023-08

3. Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation;Terapevticheskii arkhiv;2021-09-15

4. Development of Drug Substances of the Original Class III Antiarrhythmic Drugs Nibentan and Niferidyl;Pharmaceutical Chemistry Journal;2019-12